Edition:
India

Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

58.65USD
1:31am IST
Change (% chg)

$0.34 (+0.58%)
Prev Close
$58.31
Open
$57.98
Day's High
$58.67
Day's Low
$57.71
Volume
1,355,788
Avg. Vol
1,905,234
52-wk High
$64.60
52-wk Low
$42.88

Latest Key Developments (Source: Significant Developments)

Abbott's MitraClip Therapy Receives National Reimbursement In Japan To Treat Patients With Mitral Regurgitation
Monday, 19 Mar 2018 

March 19 (Reuters) - Abbott Laboratories ::ABBOTT'S MITRACLIP THERAPY RECEIVES NATIONAL REIMBURSEMENT IN JAPAN TO TREAT PATIENTS WITH MITRAL REGURGITATION.ABBOTT LABORATORIES - ‍MITRACLIP SYSTEM IS APPROVED IN JAPAN FOR TREATMENT OF BOTH SEVERE DEGENERATIVE MITRAL REGURGITATION AND FMR HEART DISEASES​.ABBOTT-MINISTRY OF HEALTH LABOUR AND WELFARE IN JAPAN GRANTED NATIONAL REIMBURSEMENT FOR CO'S MITRACLIP THERAPY TO TREAT MITRAL REGURGITATION.  Full Article

FDA Approves The World's Smallest Mechanical Heart Valve
Wednesday, 7 Mar 2018 

March 6 (Reuters) - Abbott Laboratories ::FDA APPROVES THE WORLD'S SMALLEST MECHANICAL HEART VALVE FOR PEDIATRIC PATIENTS WITH HEART DEFECTS.  Full Article

U.S. FDA Expands Approval Of A Heart Valve To Include Size For Newborn Children
Wednesday, 7 Mar 2018 

March 6 (Reuters) - U.S. Food and Drug Administration::U.S. FDA SAYS EXPANDED APPROVAL OF A HEART VALVE TO INCLUDE A SIZE SMALL ENOUGH TO BE USED IN NEWBORN PEDIATRIC PATIENTS TO TREAT HEART DEFECTS.U.S. FDA SAYS GRANTED APPROVAL OF MASTER SERIES HEART VALVE TO ST JUDE MEDICAL.U.S. FDA SAYS APPROVED THE MASTERS SERIES MECHANICAL HEART VALVE WITH HEMODYNAMIC PLUS SEWING CUFF TO INCLUDE THE 15-MM VALVE SIZE.  Full Article

Abbott And Surmodics Announce Agreement For Next-Generation Drug-Coated Balloon
Tuesday, 27 Feb 2018 

Feb 27 (Reuters) - Abbott Laboratories ::ABBOTT AND SURMODICS ANNOUNCE AGREEMENT FOR NEXT-GENERATION DRUG-COATED BALLOON.SURMODICS INC - ‍PURSUANT TO TERMS OF AGREEMENT, SURMODICS WILL RECEIVE A $25 MILLION UPFRONT PAYMENT​.SURMODICS INC - ‍PURSUANT TO TERMS OF AGREEMENT, CO MAY EARN AN ADDITIONAL $67 MILLION FOR VARIOUS PRODUCT DEVELOPMENT MILESTONES​.SURMODICS - ENTERED INTO AGREEMENT WHEREBY ABBOTT WILL HAVE EXCLUSIVE WORLDWIDE COMMERCIALIZATION RIGHTS FOR CO'S SURVEI DRUG-COATED BALLOON.SURMODICS INC - WILL BE RESPONSIBLE FOR MANUFACTURE AND SUPPLY OF CLINICAL AND COMMERCIAL QUANTITIES OF PRODUCT​.SURMODICS INC - ‍ABBOTT ALSO RECEIVED OPTIONS TO NEGOTIATE AGREEMENTS FOR CO'S BELOW-THE-KNEE AND AV FISTULA DRUG-COATED BALLOON PRODUCTS​.  Full Article

Abbott Sets Quarterly Dividend Of $0.28/Share
Friday, 16 Feb 2018 

Feb 16 (Reuters) - Abbott ::ABBOTT SETS QUARTERLY DIVIDEND OF $0.28PER SHARE.  Full Article

Agios says FDA Accepts NDA And Grants Priority Review For Ivosidenib
Thursday, 15 Feb 2018 

Feb 15 (Reuters) - Agios Pharmaceuticals Inc ::FDA ACCEPTS NEW DRUG APPLICATION AND GRANTS PRIORITY REVIEW FOR IVOSIDENIB IN RELAPSED OR REFRACTORY AML WITH AN IDH1 MUTATION.FDA ACCEPTS NEW DRUG APPLICATION AND GRANTS PRIORITY REVIEW FOR IVOSIDENIB IN RELAPSED OR REFRACTORY AML WITH AN IDH1 MUTATION.AGIOS PHARMACEUTICALS INC - ‍PDUFA DATE SET FOR AUGUST 21, 2018​.AGIOS PHARMACEUTICALS - ABBOTT SUBMITTED PREMARKET APPROVAL APPLICATION FOR FDA REVIEW OF AN IDH1 ASSAY ON ABBOTT M2000 REALTIME SYSTEM​.AGIOS PHARMACEUTICALS INC - ‍ABBOTT ASSAY WILL SERVE AS A COMPANION DIAGNOSTIC FOR IVOSIDENIB​.  Full Article

Mylan To Complete $1 Billion Share Repurchase Plan
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Mylan Nv ::MYLAN TO COMPLETE $1 BILLION SHARE REPURCHASE PLAN.MYLAN - AS PER AGREEMENT WITH ABBOTT RELATED TO ABBOTT EPD DEAL, ABBOTT NOTIFIED MYLAN IT SOLD REMAINING 20.3 MILLION IN MYLAN SHARES PRIOR TO YEAR-END​.  Full Article

Abbott gets New FDA Labeling For Some Of Its MRI-Ready Devices
Wednesday, 3 Jan 2018 

Jan 3 (Reuters) - Abbott Laboratories ::NEW FDA MR-CONDITIONAL LABELING APPROVALS FURTHER EXPAND ABBOTT'S PORTFOLIO OF MRI-READY DEVICES.  Full Article

Abbott Increases Quarterly Dividend To 28 Cents Per Share
Friday, 15 Dec 2017 

Dec 15 (Reuters) - Abbott Laboratories ::ABBOTT LABORATORIES - INCREASED COMPANY'S QUARTERLY COMMON DIVIDEND TO 28 CENTS PER SHARE FROM 26.5 CENTS PER SHARE.  Full Article

Abbott gets FDA clearance for its Alinity ci-series instruments
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Abbott Laboratories :Abbott announces FDA clearance for its Alinity ci-series next-generation diagnostic systems.Abbott laboratories - ‍secured U.S. FDA 510(k) clearance for its alinity ci-series instruments for clinical chemistry and immunoassay diagnostics​.  Full Article

BRIEF-Abbott Laboratories - Co, Sanquin Sign Multiple-Year Contract For Supply Of Primary Serological Equipment And Consumables

* ABBOTT LABORATORIES - CO, SANQUIN SIGN MULTIPLE-YEAR CONTRACT FOR SUPPLY OF PRIMARY SEROLOGICAL EQUIPMENT AND CONSUMABLES Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)